BCPEM
AMGN icon

Bain Capital Public Equity Management’s Amgen AMGN Stock Holding History

Bain Capital Public Equity Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-141,960
Closed -$26.5M – 84
2017
Q3 		$26.5M Buy
+141,960
New +$25.2M 1.67% 19

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bain Capital Public Equity Management's AMGN Position: Q4 2017 in Review

Bain Capital Public Equity Management sold out of Amgen (AMGN) in Q4 2017, closing a stake of 141,960 shares — an estimated $26.5M sold.

Bain Capital Public Equity Management first reported a position in AMGN in Q3 2017 and held it in 1 quarter. The position peaked at $26.5M in Q3 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • Bain Capital Public Equity Management reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 141,960 Amgen shares in Q4 2017, an estimated $26.5M.
  • Bain Capital Public Equity Management first reported a position in Amgen in Q3 2017 and held it in 1 quarter.
  • Bain Capital Public Equity Management's Amgen position peaked at $26.5M in Q3 2017.
  • 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Bain Capital Public Equity Management's 13F filing for Q4 2017, filed 14 Feb 2018.